| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50081 |
Neuro-2a |
mouse |
region of spinal cord |
Derivative of C1300 tumor. C1300 tumor was originally described as a spontaneous tumor of the region of spinal cord. Later studies suggested that it is drived from sympathetic cells in peripheral nervous system. |
|
| 2 | general cells |
IFO50082 |
V79 379A |
hamster, Chinese |
lung |
lung, fibroblast, widely used in somatic genetics |
|
| 3 | general cells |
IFO50418 |
ASF-4-1 |
human |
skin fibroblast from upper arm |
Normal diploid (46, XY) fibroblast with limited life span. The ASF-4-1 and the ASF-4-2 lines were established from skins of the same donor at different ages. This cell line was taken from the donor at 36 years and 2 month-old |
|
| 4 | general cells |
JCRB0007 |
Pt K2 |
marsupial (potoroo, rat kangar |
kidney |
DNA replication study |
|
| 5 | general cells |
JCRB0018 |
J774.1 |
mouse |
ascites |
monocyte-macrophage, IL-1-producing, (BALB/c mouse) |
|
| 6 | general cells |
JCRB0070 |
MIA PaCa-2 |
human |
pancreas |
pancreatic cancer |
|
| 7 | general cells |
JCRB0105.1 |
KY821A3 |
human |
peripheral blood |
leukemia, acute myeloid, subclone of KY821 |
|
| 8 | general cells |
JCRB0114 |
LC4-1 |
human |
peripheral blood |
leukemia, acute non T lymphoblastic |
|
| 9 | general cells |
JCRB0501 |
TIG-1-20 |
human |
fetus lung |
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 20 |
|
| 10 | general cells |
JCRB0734 |
3Y1-B Clone 1-6 |
rat |
embryo/fetus |
fibroblast, whole embryo, (Fischer 344 rat) |
|
| 11 | general cells |
JCRB1019 |
RERF-LC-Sq1 |
human |
lung |
Cell line established from human lung carcinoma tissue. |
|
| 12 | general cells |
JCRB1122 |
HEC-151 |
human |
uterine corpus |
Human endometrioid adenocarcinoma, G2. |
|
| 13 | general cells |
JCRB1140 |
UBE6T-6 |
human |
bone marrow |
Human bone marrow-derived mesenchymal stem cells. |
|
| 14 | general cells |
JCRB1185 |
KMS-21BM |
human |
bone marrow |
human myeloma cell line. |
|
| 15 | general cells |
JCRB1222.15 |
HGH2.4.2 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
| 16 | general cells |
JCRB1308 |
NCC-OvC-K119 |
human |
Ovary |
Huaman ovarian carcinoma cell line. |
|
| 17 | general cells |
JCRB1324 |
F119 |
mouse |
|
Mouse hybridoma cell line producing F119 MAb against CD307(IRTA2/FcRH5/FCRL5). |
|
| 18 | genetically-modified cells |
JCRB1490 |
POLZ L2618M |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLZ low fidelity, TK+/-) |
|
| 19 | general cells |
JCRB1557 |
KKU-213 |
human |
biliary tract |
Human mixed (papillary and non-papillary) cholangiocarcinoma cell line established from biliary tract. |
|
| 20 | genetically-modified cells |
JCRB1582 |
TWNT-1 |
human |
LI90 cell line |
Immortalized human hepatic stellate cell line (established from LI90). |
|
| 21 | general cells |
JCRB1599 |
hTf30-8H |
mouse x mouse |
|
This cell line produce monoclonal antibody against human transferrin. |
|
| 22 | general cells |
JCRB1752 |
XYFMGG16M |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from human XY female. |
|
| 23 | general cells |
JCRB1808 |
MOLM-1 |
human |
|
Human megakaryobalastoid cell line |
|
| 24 | general cells |
JCRB1825 |
NALM-21 |
human |
perpheral blood |
Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line. Recurrence of the same patient as NALM-20.
|
|
| 25 | general cells |
JCRB1892 |
OCUT-3 |
human |
lymph node |
human anaplastic thyroid cancer cell line |
|
| 26 | general cells |
JCRB1939 |
MKN45cL85 |
human |
stomach, metastatic tumor in liver |
Subclone of MKN45 (Human Gastric Cancer) cell line. Cachexia-inducing cell line.
|
|
| 27 | general cells |
JCRB1946 |
AkuNEC |
human |
|
Cachexia-inducing cell line, (established from duodenal neuroendocrine carcinoma TCC-NECT-2) |
|
| 28 | general cells |
JCRB4035 |
Daudi- |
human |
bood |
A clone in which EBV was dropped from Daudi+
|
|
| 29 | general cells |
JCRB4050 |
SiCry-15X |
human |
jejunum |
Small bowel adenocarcinoma
cell line using patient‑derived xenografts,
which produces CEA and CA19‑9 |
|
| 30 | general cells |
JCRB9096 |
C6 |
rat |
brain |
glial tumor, GFAP-positive |
|
| 31 | general cells |
JCRB9109 |
P3.6.2.8.1 |
mouse |
|
myeloma, IgG1 secreting, (BALB/c mouse) |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.